ZA200808017B - Tetrahydropyridothienopyrimidine compounds and methods of use thereof - Google Patents

Tetrahydropyridothienopyrimidine compounds and methods of use thereof

Info

Publication number
ZA200808017B
ZA200808017B ZA200808017A ZA200808017A ZA200808017B ZA 200808017 B ZA200808017 B ZA 200808017B ZA 200808017 A ZA200808017 A ZA 200808017A ZA 200808017 A ZA200808017 A ZA 200808017A ZA 200808017 B ZA200808017 B ZA 200808017B
Authority
ZA
South Africa
Prior art keywords
tetrahydropyridothienopyrimidine
compounds
methods
tetrahydropyridothienopyrimidine compounds
Prior art date
Application number
ZA200808017A
Other languages
English (en)
Inventor
Zhang Chengzhi
Sidhu Kanwar
Lobell Mario
Ladouceur Gaetan
Zhao Qian
Liu Zheng
Kristen M Allegue
Chetan P Darne
Newcom Jason
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200808017B publication Critical patent/ZA200808017B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200808017A 2006-03-20 2008-09-18 Tetrahydropyridothienopyrimidine compounds and methods of use thereof ZA200808017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78414606P 2006-03-20 2006-03-20

Publications (1)

Publication Number Publication Date
ZA200808017B true ZA200808017B (en) 2009-11-25

Family

ID=38523058

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808017A ZA200808017B (en) 2006-03-20 2008-09-18 Tetrahydropyridothienopyrimidine compounds and methods of use thereof

Country Status (29)

Country Link
US (1) US8501755B2 (xx)
EP (1) EP2001890B1 (xx)
JP (1) JP5282026B2 (xx)
KR (1) KR20080110834A (xx)
CN (1) CN101448840B (xx)
AR (1) AR059901A1 (xx)
AT (1) ATE495179T1 (xx)
AU (1) AU2007227317A1 (xx)
BR (1) BRPI0711045A2 (xx)
CA (1) CA2647036C (xx)
CR (1) CR10304A (xx)
DE (1) DE602007011906D1 (xx)
DO (1) DOP2007000053A (xx)
EC (1) ECSP088749A (xx)
ES (1) ES2357654T3 (xx)
GT (1) GT200800187A (xx)
IL (1) IL194028A0 (xx)
MA (1) MA30351B1 (xx)
MX (1) MX2008012006A (xx)
NZ (1) NZ571326A (xx)
PA (1) PA8719401A1 (xx)
PE (1) PE20080144A1 (xx)
RU (1) RU2008141239A (xx)
SV (1) SV2008003032A (xx)
TN (1) TNSN08370A1 (xx)
TW (1) TW200804397A (xx)
UY (1) UY30220A1 (xx)
WO (1) WO2007109279A2 (xx)
ZA (1) ZA200808017B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
ES2396602T3 (es) * 2007-09-14 2013-02-22 Bayer Intellectual Property Gmbh Compuestos tricíclicos sustituidos y procedimientos de uso de los mismos
JP5791500B2 (ja) 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ，エルエルシー． ５−リポキシゲナーゼ活性化タンパク質阻害剤
TWI385174B (zh) * 2008-11-10 2013-02-11 Nat Health Research Institutes 作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物
AU2013202373B2 (en) * 2012-01-25 2016-04-14 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
JP2017519737A (ja) * 2014-05-26 2017-07-20 バイエル・ファルマ・アクティエンゲゼルシャフト 置換テトラヒドロピリドチエノピリミジン
US10561749B2 (en) 2015-07-03 2020-02-18 Kyoto University Nuclear medicine diagnostic imaging agent
MX2018015878A (es) 2016-06-22 2019-05-27 Univ Vanderbilt Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4.
US10961253B2 (en) 2016-11-07 2021-03-30 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
EP3534901B1 (en) 2016-11-07 2022-06-22 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
BR112018013879A2 (pt) 2016-11-07 2018-12-11 Univ Vanderbilt moduladores alostéricos positivos do receptor muscarínico de acetilcolina m4
US11376254B2 (en) 2017-12-05 2022-07-05 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
EP3941905A1 (en) * 2019-03-19 2022-01-26 Suvalent Therapeutics, Inc. Sumo inhibitor compounds and uses thereof
KR20240044458A (ko) * 2021-08-05 2024-04-04 브리스톨-마이어스 스큅 컴퍼니 Her2 억제제로서 사용하기 위한 트리시클릭 융합된 피리미딘 화합물
CN114736154B (zh) * 2022-03-15 2023-07-21 安庆朗坤药业有限公司 N-（3-氯-4-（2-吡啶甲氧基）苯基）-2-氰基乙酰胺的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3453900A (en) * 1999-03-30 2000-10-23 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
US6608053B2 (en) 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
WO2005010008A1 (en) 2003-07-24 2005-02-03 Bayer Pharmaceuticals Corporation Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders

Also Published As

Publication number Publication date
GT200800187A (es) 2009-04-07
SV2008003032A (es) 2009-11-26
CR10304A (es) 2009-01-27
PE20080144A1 (es) 2008-04-06
ECSP088749A (es) 2008-10-31
DOP2007000053A (es) 2007-09-30
JP5282026B2 (ja) 2013-09-04
IL194028A0 (en) 2009-09-22
DE602007011906D1 (de) 2011-02-24
NZ571326A (en) 2011-07-29
RU2008141239A (ru) 2010-04-27
MX2008012006A (es) 2008-10-03
CA2647036A1 (en) 2007-09-27
JP2009530387A (ja) 2009-08-27
UY30220A1 (es) 2007-10-31
KR20080110834A (ko) 2008-12-19
PA8719401A1 (es) 2009-02-09
MA30351B1 (fr) 2009-04-01
AU2007227317A1 (en) 2007-09-27
CA2647036C (en) 2015-06-23
TW200804397A (en) 2008-01-16
EP2001890A2 (en) 2008-12-17
ES2357654T3 (es) 2011-04-28
CN101448840B (zh) 2011-12-14
TNSN08370A1 (en) 2009-12-29
CN101448840A (zh) 2009-06-03
AR059901A1 (es) 2008-05-07
EP2001890B1 (en) 2011-01-12
BRPI0711045A2 (pt) 2012-06-26
US8501755B2 (en) 2013-08-06
WO2007109279A3 (en) 2007-12-21
US20100298297A1 (en) 2010-11-25
WO2007109279A2 (en) 2007-09-27
ATE495179T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
EP2094085A4 (en) ANTI-CHOLESTEROLMIC COMPOUNDS AND METHODS OF USE
GB0718972D0 (en) Compounds and methods of making the compounds
HK1135099A1 (en) Aza-indolyl compounds and methods of use
IL193693A0 (en) Purine compounds and methods of use thereof
EP2021555A4 (en) STRUCTURAL ELEMENT AND METHODS OF USE THEREOF
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
IL206125A0 (en) Azaindolizines and methods of use
GB0611115D0 (en) Compounds and their use
IL192564A0 (en) Composition and method of use thereof
EP2069371A4 (en) ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
ZA201004894B (en) Nuctraceutical composition and methods of use
IL192820A0 (en) Novel compounds and use thereof
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use
ZA201004893B (en) Nuctraceutical composition and methods of use
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
ZA200807956B (en) Purine compounds and methods of use thereof
ZA200710971B (en) Elasmobranch-repelling compounds and methods of use
AU2006907075A0 (en) Compounds and Methods of Use